NTRB Quote, Financials, Valuation and Earnings

Edwards Lifesciences Corp. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of 4.09%. Nutriband, Inc.'s return on equity of -164.64% beat Edwards Lifesciences Corp.'s return on equity of 13.19%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 238.6%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $96.50 which suggests that it could grow by 20.96%. Given that Nutriband, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe Nutriband, Inc. is more attractive than Edwards Lifesciences Corp..

Nutriband, Inc. has a beta of 1.886, which suggesting that the stock is 88.601% more volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.133%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.

Nutriband, Inc. quarterly revenues are $346.1K, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Nutriband, Inc.'s net income of -$3.9M is lower than Edwards Lifesciences Corp.'s net income of $64.2M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 43.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 22.11x versus 7.70x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.

INVO Fertility, Inc. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of -150.51%. Nutriband, Inc.'s return on equity of -164.64% beat INVO Fertility, Inc.'s return on equity of -471.28%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 238.6%. On the other hand INVO Fertility, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 303.59%. Given that INVO Fertility, Inc. has higher upside potential than Nutriband, Inc., analysts believe INVO Fertility, Inc. is more attractive than Nutriband, Inc..

Nutriband, Inc. has a beta of 1.886, which suggesting that the stock is 88.601% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.650, suggesting its more volatile than the S&P 500 by 165.033%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.

Nutriband, Inc. quarterly revenues are $346.1K, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. Nutriband, Inc.'s net income of -$3.9M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 22.11x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

PetVivo Holdings, Inc. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of -765.99%. Nutriband, Inc.'s return on equity of -164.64% beat PetVivo Holdings, Inc.'s return on equity of -335.08%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 238.6%. On the other hand PetVivo Holdings, Inc. has an analysts' consensus of -- which suggests that it could grow by 614.29%. Given that PetVivo Holdings, Inc. has higher upside potential than Nutriband, Inc., analysts believe PetVivo Holdings, Inc. is more attractive than Nutriband, Inc..

Nutriband, Inc. has a beta of 1.886, which suggesting that the stock is 88.601% more volatile than S&P 500. In comparison PetVivo Holdings, Inc. has a beta of 0.306, suggesting its less volatile than the S&P 500 by 69.424%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PetVivo Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. PetVivo Holdings, Inc. pays out -- of its earnings as a dividend.

Nutriband, Inc. quarterly revenues are $346.1K, which are larger than PetVivo Holdings, Inc. quarterly revenues of $286.1K. Nutriband, Inc.'s net income of -$3.9M is lower than PetVivo Holdings, Inc.'s net income of -$2.2M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while PetVivo Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 22.11x versus 17.28x for PetVivo Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Zimmer Biomet Holdings, Inc. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of 6.15%. Nutriband, Inc.'s return on equity of -164.64% beat Zimmer Biomet Holdings, Inc.'s return on equity of 5.61%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 238.6%. On the other hand Zimmer Biomet Holdings, Inc. has an analysts' consensus of $102.65 which suggests that it could grow by 3.95%. Given that Nutriband, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Nutriband, Inc. is more attractive than Zimmer Biomet Holdings, Inc..

Nutriband, Inc. has a beta of 1.886, which suggesting that the stock is 88.601% more volatile than S&P 500. In comparison Zimmer Biomet Holdings, Inc. has a beta of 0.619, suggesting its less volatile than the S&P 500 by 38.12%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zimmer Biomet Holdings, Inc. offers a yield of 0.97% to investors and pays a quarterly dividend of $0.24 per share. Nutriband, Inc. pays -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc. pays out 27.04% of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Nutriband, Inc. quarterly revenues are $346.1K, which are smaller than Zimmer Biomet Holdings, Inc. quarterly revenues of $2.2B. Nutriband, Inc.'s net income of -$3.9M is lower than Zimmer Biomet Holdings, Inc.'s net income of $137.9M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while Zimmer Biomet Holdings, Inc.'s PE ratio is 27.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 22.11x versus 2.38x for Zimmer Biomet Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.